120
Views
17
CrossRef citations to date
0
Altmetric
Article

Prognostic Value of C-Reactive Protein to Albumin Ratio in Gastric Cancer: A Meta-Analysis

, , &
Pages 1864-1871 | Received 27 Mar 2020, Accepted 25 Aug 2020, Published online: 17 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Menglu Dai, Xiaohui Zhao, Aijun Yu, Luwen Zhao, Qingmin Kang, Shujun Yan, Xuejun Zhang & Jinlong Liu. (2022) Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients with Bile Duct Cancer: A Meta-Analysis. Nutrition and Cancer 0:0, pages 1-13.
Read now

Articles from other publishers (15)

Xuan Zhang, Yang-Yang Wu, Yuan-Yuan Qin & Fa-Quan Lin. (2024) The combined detection of hematological indicators is used for the differential diagnosis of colorectal cancer and benign-colorectal lesions. Cancer Biomarkers 39:3, pages 223-230.
Crossref
Dimitrios Papantoniou, Katarzyna Fröss‐Baron, Ulrike Garske‐Román, Anders Sundin, Espen Thiis‐Evensen, Malin Grönberg, Staffan Welin & Eva Tiensuu Janson. (2024) Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio ( dNLR ), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy : A retrospective, cohort study of 557 patients . Journal of Neuroendocrinology.
Crossref
Quan Tang, Xu Li & Chun-Rong Sun. (2024) Predictive value of serum albumin levels on cancer survival: a prospective cohort study. Frontiers in Oncology 14.
Crossref
Xiaopeng Chen, Zhaohui Chen, Jianyang Guo, Zhe Xiu & Huangxiang Chen. (2024) Preoperative plasma fibrinogen and C-reactive protein/albumin ratio as prognostic biomarkers for pancreatic carcinoma. Frontiers in Oncology 14.
Crossref
Rujia Zhang, Haoran Zhao, Peng Wang, Zuoming Guo, Chunxun Liu & Zhaowei Qu. (2023) Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors. BMC Cancer 23:1.
Crossref
Yueyue Liu, Quan Kang & Guobin Liu. (2023) Diagnosis, risk factors, and treatment of pediatric benign pneumoperitoneum: A single‐center retrospective study. Pediatric Discovery 1:3.
Crossref
Kozo Miyatani, Yu Sakano, Masahiro Makinoya, Wataru Miyauchi, Shota Shimizu, Yuji Shishido, Takehiko Hanaki, Kyoichi Kihara, Tomoyuki Matsunaga, Manabu Yamamoto, Naruo Tokuyasu, Shuichi Takano, Teruhisa Sakamoto, Toshimichi Hasegawa, Hiroaki Saito & Yoshiyuki Fujiwara. (2023) A low cumulative perioperative prognostic nutritional index predicts poor long-term outcomes in patients with gastric cancer: A single-center retrospective study in Japan. Surgery Today 53:11, pages 1294-1304.
Crossref
Masahiro Kataoka, Kuniyuki Gomi, Ken Ichioka, Takuya Iguchi, Tomoki Shirota, Arano Makino, Ko Shimada, Kiyotomi Maruyama, Motohiro Mihara & Shoji Kajikawa. (2023) Clinical impact of C-reactive protein to albumin ratio of the 7th postoperative day on prognosis after laparoscopic colorectal cancer surgery. Annals of Coloproctology 39:4, pages 315-325.
Crossref
Tomoyuki Matsunaga, Hiroaki Saito, Tomohiro Osaki, Sadamu Takahashi, Akemi Iwamoto, Kenji Fukuda, Kenjiro Taniguchi, Hirohiko Kuroda, Tsutomu Takeuchi, Kenji Sugamura, Kenichi Sumi, Kuniyuki Katano, Yuji Shishido, Kozo Miyatani & Yoshiyuki Fujiwara. (2022) Impact of geriatric nutritional risk index on outcomes after gastrectomy in elderly patients with gastric cancer: a retrospective multicenter study in Japan. BMC Cancer 22:1.
Crossref
Niklas Gebauer, Maria Ziehm, Judith Gebauer, Armin Riecke, Sebastian Meyhöfer, Birte Kulemann, Nikolas von Bubnoff, Konrad Steinestel, Arthur Bauer & Hanno M. Witte. (2022) The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro–Entero–Pancreatic (GEP-NEN) System. Cancers 14:21, pages 5465.
Crossref
Baibei Li, Huachu Deng, Biao Lei, Leijie Chen, Xinyuan Zhang & Dingran Sha. (2022) The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: A meta-analysis. Frontiers in Oncology 12.
Crossref
Taisuke Araki, Kazunari Tateishi, Masamichi Komatsu, Kei Sonehara, Satoshi Wasamoto, Shigeru Koyama, Fumiaki Yoshiike, Mineyuki Hama, Kenichi Nishie, Daichi Kondo, Toshihiko Agatsuma, Akane Kato, Munetake Takata, Shintaro Kanda, Masayuki Hanaoka & Tomonobu Koizumi. (2022) Predictive value of post‐treatment C‐reactive protein‐to‐albumin ratio in locally advanced non–small cell lung cancer patients receiving durvalumab after chemoradiotherapy . Thoracic Cancer 13:14, pages 2031-2040.
Crossref
Yao Tian, Na Liu, Hui Yin & Lihua Duan. (2022) Relationship Between C-Reactive Protein/Serum Albumin Ratio, Neutrophil/Lymphocyte Ratio, and ANCA-Associated Vasculitis Activity: A Retrospective Single Center Cohort Study. Frontiers in Medicine 9.
Crossref
Nadia Terranova, Jonathan French, Haiqing Dai, Matthew Wiens, Akash Khandelwal, Ana Ruiz‐Garcia, Juliane Manitz, Anja von Heydebreck, Mary Ruisi, Kevin Chin, Pascal Girard & Karthik Venkatakrishnan. (2022) Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab. CPT: Pharmacometrics & Systems Pharmacology 11:3, pages 333-347.
Crossref
Wen-Zhe Kang, Jian-Ping Xiong, Yang Li, Peng Jin, Yi-Bin Xie, Quan Xu, Yu-Xin Zhong & Yan-Tao Tian. (2022) A New Scoring System to Predict Lymph Node Metastasis and Prognosis After Surgery for Gastric Cancer. Frontiers in Oncology 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.